DarioHealth Corp.
corporate_fare Company Profile
DarioHealth Corp. (NASDAQ:DRIO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for DRIO at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- DarioHealth Projected to Post $3.24/Share Loss, Revenue Down 33% Ahead of Earnings
- DarioHealth Sees Strong Demand for Oral GLP-1 Solution
- Shareholders Approve Significant Dilution from Past Financings and Future Equity Plan
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$22.36M
Net Income
-$41.71M
Diluted EPS
$10.12
Op. Cash Flow
-$25.94M
Free Cash Flow
-$26.08M
Gross Profit
$12.66M
Operating Income
-$36.66M
Cash & Equivalents
$21.8M
Total Debt
$30.75M
Debt / Equity
0.45×
Net Margin
-186.6%
Shares Outstanding
6.91M sh
Source: 10-K · filed 2026-03-19 · accession 0001104659-26-031621
show_chartPrice Chart
Loading chart...
feed DRIO - Filings & News (Page 2)
DRIO
Mar 06, 2026, 7:34 AM EST
Price at Filing:
$9.21
Real-time Price:
$1.32
Change:
-$7.89 (-86%)
Market Cap:
$14.899M
DRIO
Mar 03, 2026, 8:02 AM EST
Price at Filing:
$10.75
Real-time Price:
$1.32
Change:
-$9.43 (-88%)
Market Cap:
$14.899M
DRIO
Jan 29, 2026, 4:06 PM EST
Price at Filing:
$10.30
Real-time Price:
$1.32
Change:
-$8.98 (-87%)
Market Cap:
$14.899M